**CAR-T Therapy Boosts Leukaemia Survival** Exciting news in oncology! The NHS has expanded its pioneering CAR-T therapy, offering a "living drug" to adult leukaemia patients. Oscar Murphy, the first to receive this breakthrough for B-cell ALL, described it as "very sci-fi" (BBC, January 14, 2026). This personalized treatment, involving genetically modified T-cells, marks a significant step forward. Globally, cancer survival rates are improving, with 7 in 10 patients now surviving five years or more post-diagnosis, thanks to enhanced detection and treatment options (NBC News, January 13, 2026). Researchers continue to explore novel immunotherapies to overcome treatment resistance, offering new hope. For a deeper dive into ongoing research, see Cancer Research in 2025 (https://www.youtube.com/watch?v=yptOG--Mz88). #News #CancerTreatment #MedicalBreakthrough #Oncology